Desjardins analyst A. Leon now anticipates that the company will post earnings per share of $0.06 for the year, […] ...
Equities researchers at HC Wainwright issued their FY2025 earnings per share estimates for shares of Virax Biolabs Group in a research note issued to investors on Monday, March 31st. HC Wainwright ...
Scientists found that pseudouridine helps small RNAs pass on traits and avoid immune detection, offering clues for future RNA ...
Several studies have been conducted, but questions remain about where such therapies will fit into multiple myeloma treatment ...
COPENHAGEN, Denmark, April 1, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, provides business ...
In recent years, the familiar symptoms of the flu might kick us into reaching for at-home testing kits. But on the eve of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results